These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8796337)
41. Dissociation of serum prolactin response to sequential thyrotropin-releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome. Futterweit W; Smith H; Holt JE Fertil Steril; 1984 Oct; 42(4):573-8. PubMed ID: 6436062 [TBL] [Abstract][Full Text] [Related]
42. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography. Shangold GA; Kletzky OA; Marrs RP; Mishell DR Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715 [TBL] [Abstract][Full Text] [Related]
43. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats. Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651 [TBL] [Abstract][Full Text] [Related]
44. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma. Brismar K; Hulting AL; Werner S J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920 [TBL] [Abstract][Full Text] [Related]
45. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients. Duval F; Mokrani MC; Erb A; Gonzalez Opera F; Calleja C; Paris V Psychoneuroendocrinology; 2017 Nov; 85():100-109. PubMed ID: 28843902 [TBL] [Abstract][Full Text] [Related]
46. Prolactin response to the dopamine antagonists sulpiride and domperidone. Further evidence for pituitary dopamine deficiency in hyperprolactinemic disorders of different etiology. Ferrari C; Scarduelli C; Rampini P; Brambilla G; Benco R; Pistolesi E; Paracchi A; Mattei A; Boghen M; Crosignani PG Gynecol Obstet Invest; 1983; 16(5):299-306. PubMed ID: 6642291 [TBL] [Abstract][Full Text] [Related]
47. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. De Marinis L; Mancini A; Maira G; Anile C; Menini E; Barbarino A J Clin Endocrinol Metab; 1984 Mar; 58(3):405-9. PubMed ID: 6693543 [TBL] [Abstract][Full Text] [Related]
48. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone]. Schlienger JL; De Laharpe F; Reville P; Stephan F Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964 [TBL] [Abstract][Full Text] [Related]
49. Comparative maturation of the regulation of prolactin and thyrotropin by serotonin and thyrotropin-releasing hormone in male and female rats. Becú D; Libertun C Endocrinology; 1982 Jun; 110(6):1879-84. PubMed ID: 6804214 [TBL] [Abstract][Full Text] [Related]
50. Monoamine regulation of prolactin and TSH secretion in hypothyroidism. Gerasimov G; Chernova T; Goncharov N Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463 [TBL] [Abstract][Full Text] [Related]
51. Interrelationship between TSH- and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis. Pelkonen R; Salmi J; Lamberg BA Acta Endocrinol (Copenh); 1982 Jun; 100(2):184-8. PubMed ID: 6810613 [TBL] [Abstract][Full Text] [Related]
53. Use of a pharmacokinetic model to characterize the thyrotropin (TSH) and prolactin (PRL) response to thyrotropin-releasing hormone (THR) in man. Perret G; Valensi P; Hugues JN; Vassy R; Uzzan B Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):387-91. PubMed ID: 3137402 [TBL] [Abstract][Full Text] [Related]
54. Growth rate and secretion of pituitary hormones in relation to age and chronic treatment with thyrotropin-releasing hormone in prepubertal dairy heifers. Davis SL; Sasser RG; Thacker DL; Ross RH Endocrinology; 1977 May; 100(5):1394-402. PubMed ID: 191244 [TBL] [Abstract][Full Text] [Related]
55. Evidence that thyrotropin-releasing hormone is not a major prolactin-releasing factor during suckling in the rat. Riskind PN; Millard WJ; Martin JB Endocrinology; 1984 Jul; 115(1):312-6. PubMed ID: 6329654 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma. Xia P; Shi YF Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):121-5. PubMed ID: 2594732 [TBL] [Abstract][Full Text] [Related]
57. On the role of dopamine receptors in the central regulation of human TSH. Delitala G; Devilla L; Canessa A; D'Asta F Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078 [TBL] [Abstract][Full Text] [Related]
58. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia. Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986 [TBL] [Abstract][Full Text] [Related]
59. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects. Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316 [TBL] [Abstract][Full Text] [Related]
60. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC; Chen FW; Hsieh HC Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]